Interspecies Pharmacokinetics. 1. Allometric Scaling of Pharmacokinetic Parameters (a Review)

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Pharmaceutical Chemistry Journal

• Publication date

  2014-11-07

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s11094-014-1124-5
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Experimental pharmacokinetics of niferidil upon intravenous administration

  2013cited by this paper
• Contrasting toxicokinetic evaluations and interspecies pharmacokinetic scaling approaches for small molecules and biologics: applicability to biosimilar development

  2013cited by this paper
• Interspecies scaling: prediction of human biliary clearance and comparison with QSPKR

  2012cited by this paper
• An interspecies extrapolation of the pharmacokinetics of telavancin, a rapidly bactericidal, concentration-dependent antibiotic

  2011cited by this paper
• Comparative assessment of empirical and physiological approaches on predicting human clearances.

  2011cited by this paper
• MOLECULAR-BIOLOGICAL PROBLEMS OF DRUG DESIGN AND MECHANISMS OF DRUG ACTION COMPARATIVE ANALYSIS OF THE EXPERIMENTAL AND CLINICAL PHARMACOKINETICS OF AMIODARONE

  2011cited by this paper
• Preclinical Metabolism and Disposition of SB939 (Pracinostat), an Orally Active Histone Deacetylase Inhibitor, and Prediction of Human Pharmacokinetics

  2011cited by this paper
• Pharmacokinetic Allometric Scaling of Oligonucleotides

  2011cited by this paper
• Prediction of Oral Pharmacokinetics of cMet Kinase Inhibitors in Humans: Physiologically Based Pharmacokinetic Model Versus Traditional One-Compartment Model

  2011cited by this paper
• Scaling laws for plasma concentrations and tolerable doses of anticancer drugs.

  2010cited by this paper
• Interspecies allometric scaling.

  2010cited by this paper
• Similarity of Bisphenol A Pharmacokinetics in Rhesus Monkeys and Mice: Relevance for Human Exposure

  2010cited by this paper
• Pharmacokinetics of thiophane upon intragastric administration

  2010cited by this paper
• Interspecies Scaling of Receptor-Mediated Pharmacokinetics and Pharmacodynamics of Type I Interferons

  2010cited by this paper
• Effect of Oral Ketoconazole on Oral and Intravenous Pharmacokinetics of Simvastatin and Its Acid in Cynomolgus Monkeys

  2009cited by this paper
• Exploration of the African Green Monkey as a Preclinical Pharmacokinetic Model: Intravenous Pharmacokinetic Parameters

  2008cited by this paper
• Allometric scaling of xenobiotic clearance: Uncertainty versus universality

  2008cited by this paper
• Predicting Human Tumor Drug Concentrations from a Preclinical Pharmacokinetic Model of Temozolomide Brain Disposition

  2007cited by this paper
• Interspecies Prediction of Human Drug Clearance Based on Scaling Data from One or Two Animal Species

  2007cited by this paper
• Interspecies Comparisons of Pharmacokinetics and Pharmacodynamics of Recombinant Human Erythropoietin

  2007cited by this paper
• Is the Monkey an Appropriate Animal Model to Examine Drug-Drug Interactions Involving Renal Clearance? Effect of Probenecid on the Renal Elimination of H2 Receptor Antagonists

  2006cited by this paper
• A Novel Strategy for Physiologically Based Predictions of Human Pharmacokinetics

  2006cited by this paper
• A NOVEL MODEL FOR PREDICTION OF HUMAN DRUG CLEARANCE BY ALLOMETRIC SCALING

  2005cited by this paper
• Allometric relationships between the pharmacokinetics of propofol in rats, children and adults.

  2005cited by this paper
• A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. I. Clearance.

  2004cited by this paper
• THE CHIMPANZEE (PAN TROGLODYTES) AS A PHARMACOKINETIC MODEL FOR SELECTION OF DRUG CANDIDATES: MODEL CHARACTERIZATION AND APPLICATION

  2004cited by this paper
• A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. II. Volume of distribution and mean residence time.

  2004cited by this paper
• Absorption, pharmacokinetics and excretion of levovirin in rats, dogs and cynomolgus monkeys.

  2003cited by this paper
• Pharmacokinetics and allometric scaling of levormeloxifene, a selective oestrogen receptor modulator

  2003cited by this paper
• Metabolism and disposition of novel des-fluoro quinolone garenoxacin in experimental animals and an interspecies scaling of pharmacokinetic parameters.

  2003cited by this paper
• Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safety.

  2001cited by this paper
• Animal Pharmacokinetics and Interspecies Scaling of Sordarin Derivatives following Intravenous Administration

  2001cited by this paper
• Pharmacokinetics, pharmacodynamics, allometry, and dose selection of rPSGL-Ig for phase I trial.

  2000cited by this paper
• Preclinical pharmacokinetics and interspecies scaling of a novel vitronectin receptor antagonist.

  1999cited by this paper
• Preclinical pharmacokinetics, interspecies scaling, and tissue distribution of a humanized monoclonal antibody against vascular endothelial growth factor.

  1999cited by this paper
• Interspecies scaling of clearance and volume of distribution for horse antivenom F(ab')2.

  1998cited by this paper
• Prediction of human pharmacokinetics of panipenem-betamipron, a new carbapenem, from animal data

  1992cited by this paper
• Interspecies metabolism and pharmacokinetic scaling of theophylline disposition.

  1990cited by this paper
• Prediction of the pharmacokinetics of cefodizime and cefotetan in humans from pharmacokinetic parameters in animals.

  1990cited by this paper
• Definitions and applications of mean transit and residence times in reference to the two-compartment mammillary plasma clearance model.

  1988cited by this paper
• Physiological pharmacokinetic models: principles, applications, limitations and outlook.

  1986cited by this paper
• Interspecies scaling of regional drug delivery.

  1986cited by this paper
• Man versus beast: pharmacokinetic scaling in mammals.

  1986cited by this paper
• Scaling: why is animal size so important?

  1985cited by this paper
• Forecasting cephalosporin and monobactam antibiotic half-lives in humans from data collected in laboratory animals

  1985cited by this paper
• Pharmacokinetics of nipradilol (K-351), a new antihypertensive agent. I. Studies on interspecies variation in laboratory animals.

  1985cited by this paper
• Pharmacokinetic scale-up: accurate prediction of human pharmacokinetic profiles from animal data.

  1985cited by this paper
• Interspecies comparison of in vivo caffeine pharmacokinetics in man, monkey, rabbit, rat, and mouse.

  1984cited by this paper
• Interspecies pharmacokinetic scaling and the evolutionary-comparative paradigm.

  1984cited by this paper
• Definition of pharmacokinetic parameters: Influence of the sampling site

  1984cited by this paper
• Prediction of the disposition ofβ-lactam antibiotics in humans from pharmacokinetic parameters in animals

  1984cited by this paper
• Physiologically based pharmacokinetic modeling: principles and applications.

  1983cited by this paper
• Topics in Pharmaceutical Sciences

  1983cited by this paper
• Evolutionary biology, animal behavior, fourth-dimensional space, and the raison d'etre of drug metabolism and pharmacokinetics.

  1983cited by this paper
• Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics

  1982cited by this paper
• Comparative pharmacokinetics of benzodiazepines in dog and man

  1982cited by this paper
• Noncompartmental determination of the steady-state volume of distribution for any mode of administration.

  1982cited by this paper
• Applied regression analysis 2nd ed.

  1981cited by this paper
• Primer of biostatistics : statistical software program version 6.0

  1981cited by this paper
• Statistical moments in pharmacokinetics

  1978cited by this paper
• Animal scale-up

  1973cited by this paper
• Applied Regression Analysis.

  1967cited by this paper
• Organ Weights in Primates and Other Mammals

  1965cited by this paper
• Quantitative Relations in the Physiological Constitutions of Mammals.

  1949cited by this paper

• Prediction of Multi-Pharmacokinetics Property in Multi-Species: Bayesian Neural Network Stacking Model with Uncertainty.

  2024cites this paper
• Model-informed drug development for antimicrobials: translational pharmacokinetic-pharmacodynamic modelling of apramycin to facilitate prediction of efficacious dose in complicated urinary tract infections

  2024cites this paper
• A phase 1 trial of 4-(N-(S-penicillaminylacetyl)amino)-phenylarsonous acid (PENAO) in patients with advanced solid tumours

  2021cites this paper
• Model‐Informed Drug Development for Antimicrobials: Translational PK and PK/PD Modeling to Predict an Efficacious Human Dose for Apramycin

  2020cites this paper
• Elimination Half-Life of Short Peptide Drugs in Humans Extrapolated From Animal Pharmacokinetic Pharmacokinetic Studies

  2019cites this paper
• Method Development for Quantitative Determination of Ormustine in Biological Fluids by High Performance Liquid Chromatography with Mass-Spectrometric Detection

  2016cites this paper